Geymonat

Geymonat S.p.A. was a long-standing Italian pharmaceutical company headquartered in Anagni, Italy, with a history dating back to 1928. The company specialized in the manufacturing and marketing of a diverse range of pharmaceutical products, including respiratory treatments, anti-infectives, and probiotics. Geymonat was particularly recognized for its probiotic brand Biogermin and its involvement in the respiratory market with products like Aliflus. Following significant financial difficulties and regulatory challenges in 2013, the company's assets and production facilities were acquired by Istituto Biochimico Italiano (IBI) Giovanni Lorenzini. Today, the Anagni site continues to operate under IBI's management, maintaining the legacy of Geymonat's core product portfolio.